U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Substance-related disorder

MedGen UID:
66746
•Concept ID:
C0236969
•
Mental or Behavioral Dysfunction
Synonyms: Disorder, Substance Related; Disorders, Substance Related; Related Disorder, Substance; Related Disorders, Substance; Substance Related Disorder; Substance-Related Disorders
 
Monarch Initiative: MONDO:0002494

Definition

A category of psychiatric disorders which include disorders related to the taking of a drug of abuse (including alcohol, prescribed medications and recreational drugs). [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVSubstance-related disorder

Professional guidelines

PubMed

Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials.
Acheson LS, Williams BH, Farrell M, McKetin R, Ezard N, Siefried KJ
Drug Alcohol Rev 2023 Jan;42(1):7-19. Epub 2022 Jul 21 doi: 10.1111/dar.13511. PMID: 35862266Free PMC Article
Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment.
Mahoney JJ 3rd, Hanlon CA, Marshalek PJ, Rezai AR, Krinke L
J Neurol Sci 2020 Nov 15;418:117149. Epub 2020 Sep 20 doi: 10.1016/j.jns.2020.117149. PMID: 33002757Free PMC Article
Borderline personality disorder and comorbid addiction: epidemiology and treatment.
Kienast T, Stoffers J, Bermpohl F, Lieb K
Dtsch Arztebl Int 2014 Apr 18;111(16):280-6. doi: 10.3238/arztebl.2014.0280. PMID: 24791755Free PMC Article

Recent clinical studies

Etiology

Effects of brief cognitive behavioral therapy on mental health in substance-related disorder: a randomized controlled trial.
Alavi SMA, Irani RD, Fattahi P, Pakseresht S
BMC Psychiatry 2023 Dec 8;23(1):924. doi: 10.1186/s12888-023-05413-4. PMID: 38066514Free PMC Article
Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders.
Chapoutot M, Peter-Derex L, Bastuji H, Leslie W, Schoendorff B, Heinzer R, Siclari F, Nicolas A, Lemoine P, Higgins S, Bourgeois A, Vallet GT, Anders R, Ounnoughene M, Spencer J, Meloni F, Putois B
Int J Environ Res Public Health 2021 Sep 28;18(19) doi: 10.3390/ijerph181910222. PMID: 34639523Free PMC Article
Cosmetic procedure use as a type of substance-related disorder.
Shah P, Rangel LK, Geronemus RG, Rieder EA
J Am Acad Dermatol 2021 Jan;84(1):86-91. Epub 2020 Sep 10 doi: 10.1016/j.jaad.2020.08.123. PMID: 32920038
Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment.
Mahoney JJ 3rd, Hanlon CA, Marshalek PJ, Rezai AR, Krinke L
J Neurol Sci 2020 Nov 15;418:117149. Epub 2020 Sep 20 doi: 10.1016/j.jns.2020.117149. PMID: 33002757Free PMC Article
Borderline personality disorder and comorbid addiction: epidemiology and treatment.
Kienast T, Stoffers J, Bermpohl F, Lieb K
Dtsch Arztebl Int 2014 Apr 18;111(16):280-6. doi: 10.3238/arztebl.2014.0280. PMID: 24791755Free PMC Article

Diagnosis

Cosmetic procedure use as a type of substance-related disorder.
Shah P, Rangel LK, Geronemus RG, Rieder EA
J Am Acad Dermatol 2021 Jan;84(1):86-91. Epub 2020 Sep 10 doi: 10.1016/j.jaad.2020.08.123. PMID: 32920038
Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment.
Mahoney JJ 3rd, Hanlon CA, Marshalek PJ, Rezai AR, Krinke L
J Neurol Sci 2020 Nov 15;418:117149. Epub 2020 Sep 20 doi: 10.1016/j.jns.2020.117149. PMID: 33002757Free PMC Article
Incident Substance Use Disorder Following Anxiety Disorder in Privately Insured Youth.
Bushnell GA, Gaynes BN, Compton SN, Dusetzina SB, Olfson M, Stürmer T
J Adolesc Health 2019 Oct;65(4):536-542. Epub 2019 Jul 17 doi: 10.1016/j.jadohealth.2019.05.007. PMID: 31326248Free PMC Article
The generalizability of the structure of substance abuse and antisocial behavioral syndromes: A systematic review.
Soe-Agnie SE, Paap MCS, VanDerNagel JEL, Nijman HJM, de Jong CAJ
Psychiatry Res 2018 Jan;259:412-421. Epub 2017 Nov 4 doi: 10.1016/j.psychres.2017.11.007. PMID: 29120851
Borderline personality disorder and comorbid addiction: epidemiology and treatment.
Kienast T, Stoffers J, Bermpohl F, Lieb K
Dtsch Arztebl Int 2014 Apr 18;111(16):280-6. doi: 10.3238/arztebl.2014.0280. PMID: 24791755Free PMC Article

Therapy

Effects of brief cognitive behavioral therapy on mental health in substance-related disorder: a randomized controlled trial.
Alavi SMA, Irani RD, Fattahi P, Pakseresht S
BMC Psychiatry 2023 Dec 8;23(1):924. doi: 10.1186/s12888-023-05413-4. PMID: 38066514Free PMC Article
Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders.
Chapoutot M, Peter-Derex L, Bastuji H, Leslie W, Schoendorff B, Heinzer R, Siclari F, Nicolas A, Lemoine P, Higgins S, Bourgeois A, Vallet GT, Anders R, Ounnoughene M, Spencer J, Meloni F, Putois B
Int J Environ Res Public Health 2021 Sep 28;18(19) doi: 10.3390/ijerph181910222. PMID: 34639523Free PMC Article
Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment.
Mahoney JJ 3rd, Hanlon CA, Marshalek PJ, Rezai AR, Krinke L
J Neurol Sci 2020 Nov 15;418:117149. Epub 2020 Sep 20 doi: 10.1016/j.jns.2020.117149. PMID: 33002757Free PMC Article
Borderline personality disorder and comorbid addiction: epidemiology and treatment.
Kienast T, Stoffers J, Bermpohl F, Lieb K
Dtsch Arztebl Int 2014 Apr 18;111(16):280-6. doi: 10.3238/arztebl.2014.0280. PMID: 24791755Free PMC Article
Therapeutic communities for substance related disorder.
Smith LA, Gates S, Foxcroft D
Cochrane Database Syst Rev 2006 Jan 25;(1):CD005338. doi: 10.1002/14651858.CD005338.pub2. PMID: 16437526

Prognosis

Violence-related morbidity among people released from prison in Australia: A data linkage study.
Willoughby M, Keen C, Young JT, Spittal MJ, Borschmann R, Janca E, Kinner SA
Drug Alcohol Rev 2022 Feb;41(2):457-466. Epub 2021 Sep 12 doi: 10.1111/dar.13380. PMID: 34510627
Effectiveness of tianeptine in patients with major depressive disorder and substance use disorder.
Szerman N, Arias F, Algorta J, Basurte I, Vega P, Roncero C, Martínez-Raga J, Grau-López L
Actas Esp Psiquiatr 2021 Jul;49(4):135-144. Epub 2021 Jul 1 PMID: 34195969
Incident Substance Use Disorder Following Anxiety Disorder in Privately Insured Youth.
Bushnell GA, Gaynes BN, Compton SN, Dusetzina SB, Olfson M, Stürmer T
J Adolesc Health 2019 Oct;65(4):536-542. Epub 2019 Jul 17 doi: 10.1016/j.jadohealth.2019.05.007. PMID: 31326248Free PMC Article
Predictors of Electroconvulsive Therapy Use in a Large Inpatient Psychiatry Population.
Knight J, Jantzi M, Hirdes J, Rabinowitz T
J ECT 2018 Mar;34(1):35-39. doi: 10.1097/YCT.0000000000000461. PMID: 29023285
Traumatic Brain Injury and Substance Related Disorder: A 10-Year Nationwide Cohort Study in Taiwan.
Wu CH, Tsai TH, Su YF, Zhang ZH, Liu W, Wu MK, Chang CH, Kuo KL, Lu YY, Lin CL
Neural Plast 2016;2016:8030676. Epub 2016 Sep 27 doi: 10.1155/2016/8030676. PMID: 27774322Free PMC Article

Clinical prediction guides

Effects of brief cognitive behavioral therapy on mental health in substance-related disorder: a randomized controlled trial.
Alavi SMA, Irani RD, Fattahi P, Pakseresht S
BMC Psychiatry 2023 Dec 8;23(1):924. doi: 10.1186/s12888-023-05413-4. PMID: 38066514Free PMC Article
Attitude of community pharmacists toward patients with a substance-related disorder (heroin, alcohol and tobacco), estimation of harmfulness and knowledge of these substances, and continuing education: A pilot cross-sectional study.
Balayssac D, Pereira B, Julien E, Chennell P, Brousse G, Laporte C, Authier N, Vennat B
Ann Pharm Fr 2022 Nov;80(6):897-905. Epub 2022 Jun 3 doi: 10.1016/j.pharma.2022.05.005. PMID: 35667462
Violence-related morbidity among people released from prison in Australia: A data linkage study.
Willoughby M, Keen C, Young JT, Spittal MJ, Borschmann R, Janca E, Kinner SA
Drug Alcohol Rev 2022 Feb;41(2):457-466. Epub 2021 Sep 12 doi: 10.1111/dar.13380. PMID: 34510627
Prevalence of substance use disorder comorbidity among individuals with eating disorders: A systematic review and meta-analysis.
Bahji A, Mazhar MN, Hudson CC, Nadkarni P, MacNeil BA, Hawken E
Psychiatry Res 2019 Mar;273:58-66. Epub 2019 Jan 4 doi: 10.1016/j.psychres.2019.01.007. PMID: 30640052
Risk of stroke in prescription and other amphetamine-type stimulants use: A systematic review.
Indave BI, Sordo L, Bravo MJ, Sarasa-Renedo A, Fernández-Balbuena S, De la Fuente L, Sonego M, Barrio G
Drug Alcohol Rev 2018 Jan;37(1):56-69. Epub 2017 May 8 doi: 10.1111/dar.12559. PMID: 28485090

Recent systematic reviews

Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials.
Acheson LS, Williams BH, Farrell M, McKetin R, Ezard N, Siefried KJ
Drug Alcohol Rev 2023 Jan;42(1):7-19. Epub 2022 Jul 21 doi: 10.1111/dar.13511. PMID: 35862266Free PMC Article
Prevalence of substance use disorder comorbidity among individuals with eating disorders: A systematic review and meta-analysis.
Bahji A, Mazhar MN, Hudson CC, Nadkarni P, MacNeil BA, Hawken E
Psychiatry Res 2019 Mar;273:58-66. Epub 2019 Jan 4 doi: 10.1016/j.psychres.2019.01.007. PMID: 30640052
The generalizability of the structure of substance abuse and antisocial behavioral syndromes: A systematic review.
Soe-Agnie SE, Paap MCS, VanDerNagel JEL, Nijman HJM, de Jong CAJ
Psychiatry Res 2018 Jan;259:412-421. Epub 2017 Nov 4 doi: 10.1016/j.psychres.2017.11.007. PMID: 29120851
Risk of stroke in prescription and other amphetamine-type stimulants use: A systematic review.
Indave BI, Sordo L, Bravo MJ, Sarasa-Renedo A, Fernández-Balbuena S, De la Fuente L, Sonego M, Barrio G
Drug Alcohol Rev 2018 Jan;37(1):56-69. Epub 2017 May 8 doi: 10.1111/dar.12559. PMID: 28485090
Therapeutic communities for substance related disorder.
Smith LA, Gates S, Foxcroft D
Cochrane Database Syst Rev 2006 Jan 25;(1):CD005338. doi: 10.1002/14651858.CD005338.pub2. PMID: 16437526

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • MeSH
      Related Medical Subject Headings
    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...